Mirosław Kozłowski Selected Research

Mirosław Kozłowski Research Topics

Disease

12	Neoplasms (Cancer) 05/2019 - 01/2008
10	Esophageal Neoplasms (Esophageal Cancer) 10/2017 - 01/2008
4	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2016 - 03/2008
3	Neoplasm Metastasis (Metastasis) 01/2011 - 09/2009
2	Pulmonary Arterial Hypertension 06/2020 - 05/2013
2	Carcinoma (Carcinomatosis) 06/2020 - 01/2020
2	Lymphatic Metastasis 01/2017 - 12/2015
2	Esophageal Squamous Cell Carcinoma 10/2016 - 09/2009
2	Lung Neoplasms (Lung Cancer) 01/2009 - 01/2007
1	Hypertension (High Blood Pressure) 01/2020
1	Overweight 01/2020
1	Fibrosis (Cirrhosis) 01/2017
1	Residual Neoplasm 12/2015
1	Adenocarcinoma Of Esophagus 02/2012
1	Adenocarcinoma 02/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2012
1	Cardiogenic Shock 11/2007
1	Vascular Diseases (Vascular Disease) 11/2007
1	Pulmonary Hypertension 11/2007
1	Hypotension (Low Blood Pressure) 11/2007
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2007

Drug/Important Bio-Agent (IBA)

5	Tumor Biomarkers (Tumor Markers)IBA 05/2019 - 03/2008
5	squamous cell carcinoma-related antigenIBA 01/2016 - 03/2008
4	AntigensIBA 01/2016 - 03/2008
3	Carcinoembryonic AntigenIBA 02/2012 - 03/2008
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 09/2009 - 01/2008
2	Messenger RNA (mRNA)IBA 01/2017 - 12/2015
2	Metalloproteases (Metalloproteinases)IBA 01/2017 - 09/2009
2	ChemokinesIBA 01/2017 - 01/2016
2	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 03/2008
2	C-Reactive ProteinIBA 01/2016 - 02/2012
2	Collagen Type IV (Type IV Collagen)IBA 09/2009 - 01/2008
2	Peptide Hydrolases (Proteases)FDA Link 09/2009 - 01/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2009 - 01/2007
1	Serotonin ReceptorsIBA 06/2020
1	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2020
1	iberiotoxinIBA 01/2020
1	capsazepineIBA 01/2020
1	iodopravadoline (AM 630)IBA 01/2020
1	AM 251 (AM251)IBA 01/2020
1	TRAM 34IBA 01/2020
1	L-161982IBA 01/2020
1	(2-(4-(4-isopropoxybenzyl)-phenylamino) imidazoline)IBA 01/2020
1	Acetates (Acetic Acid Esters)FDA Link 01/2020
1	CannabidiolIBA 01/2020
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2020
1	ProstaglandinsIBA 01/2020
1	SaltsIBA 01/2020
1	Cyclooxygenase InhibitorsIBA 01/2020
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2020
1	nimesulide (Aulin)IBA 01/2020
1	Stem Cell FactorIBA 10/2017
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2017
1	vasectrin IIIIBA 01/2017
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 10/2016
1	Chemokine CXCL12IBA 01/2016
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 12/2015
1	Vascular Endothelial Growth Factor CIBA 12/2015
1	Vascular Endothelial Growth Factor DIBA 12/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2013
1	AntibodiesIBA 01/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2010
1	Macrophage Colony-Stimulating FactorIBA 10/2010
1	Death-Associated Protein KinasesIBA 01/2009
1	EndopeptidasesIBA 03/2008
1	ZincIBA 03/2008
1	EnzymesIBA 01/2008
1	Formaldehyde (Formol)FDA Link 01/2008
1	anandamide (arachidonylethanolamide)IBA 11/2007
1	4-(3-3,4-p-menthadien-(1,8)-yl)olivetolIBA 11/2007
1	EndocannabinoidsIBA 11/2007
1	Poly Adenosine Diphosphate RiboseIBA 01/2007
1	Serine (L-Serine)FDA Link 01/2007
1	Proteins (Proteins, Gene)FDA Link 01/2007

Therapy/Procedure

2	Therapeutics 06/2020 - 10/2016
1	Combined Modality Therapy 10/2016
1	Drug Therapy (Chemotherapy) 01/2007